Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Cancer Lett. 2011 Apr 1;303(1):56–64. doi: 10.1016/j.canlet.2011.01.016

Figure 1.

Figure 1

Kaplan-Meier survival plots confirm MYCN amplification as a significant risk factor in the 144 tumor dataset profiled for miRNA expression (A and B). Association between the lack of miR-542-5p expression (expression = 0) and lower EFS (p value = 0.0002) and OS (p value = 0.0013) (C and D).